Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans <i>In Vivo</i>

<div>The effect of several antioxidants used as competitors in the monoclonal anti-MDA-LDL IgM ELISA. Aldehyde residues of MDA were reduced, presumably to alcohols, by antioxidants, thus precluding binding of the MCA.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans <i>In Vivo</i> 

Figure 5 | Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans In Vivo 